Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) IPO
IPO
Priced at US$18.00 a share on Apr 2, 2020.
- Price
- US$18.00 a share
- Shares offered
- 9,180,000 shares of common stock
- Offering size
- US$165.2 million
- Underwriters' option
- Up to 1,377,000 more shares
- Underwriters
- Morgan Stanley, Jefferies, SVB Leerink, Guggenheim Securities · In the order on the cover
- Shares delivered
- On or about Apr 7, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 8, 2020 |
| Filed publicly | Mar 6, 2020 |
| Amended twice | Newest Mar 31, 2020 |
| Shares registered with an exchange | Apr 2, 2020 |
| Declared effective by the SEC | Apr 2, 2020 |
| Final prospectus, with the price | Apr 6, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 6, 2020 |
| CERT · Exchange's certificate of listing | Apr 3, 2020 |
| EFFECT · Notice that a registration is effective | Apr 2, 2020 |
| S-1MEF · Registration of more shares for the same offering | Apr 2, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 2, 2020 |
| CORRESP · Letter to the SEC | Mar 31, 2020 |
| CORRESP · Letter to the SEC | Mar 31, 2020 |
| S-1/A · Registration statement, amended | Mar 31, 2020 |
| S-1/A · Registration statement, amended | Mar 30, 2020 |
| CORRESP · Letter to the SEC | Mar 13, 2020 |
| CORRESP · Letter to the SEC | Mar 13, 2020 |
| UPLOAD · Letter from the SEC | Mar 11, 2020 |
| S-1 · Registration statement | Mar 6, 2020 |
| DRSLTR · Letter to the SEC with a draft | Feb 14, 2020 |
| DRS/A · Draft registration statement, amended | Feb 14, 2020 |
| UPLOAD · Letter from the SEC | Feb 11, 2020 |
| DRS · Draft registration statement | Jan 8, 2020 |
From the cover of the final prospectus (424B4) filed Apr 6, 2020